PEAK6 Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$5.28M Buy
41,800
+31,900
+322% +$3.88M 0.02% 741
2018
Q1
$1.07M Sell
9,900
-40,500
-80% -$4.48M ﹤0.01% 1900
2017
Q4
$5.52M Buy
50,400
+20,300
+67% +$2.03M 0.03% 766
2017
Q3
$2.97M Buy
+30,100
New +$2.92M 0.02% 1086
2017
Q2
Sell
-9,400
Closed -$1.09M 4593
2017
Q1
$1.09M Sell
9,400
-100
-1% -$11.6K 0.01% 1607
2016
Q4
$1.14M Buy
9,500
+700
+8% +$77.5K 0.01% 1747
2016
Q3
$989K Sell
8,800
-21,900
-71% -$2.52M 0.01% 1783
2016
Q2
$3.8M Buy
+30,700
New +$3.71M 0.03% 830
2016
Q1
Sell
-22,000
Closed -$2.39M 4454
2015
Q4
$2.39M Sell
22,000
-8,200
-27% -$939K 0.02% 1206
2015
Q3
$3.01M Buy
30,200
+15,200
+101% +$1.65M 0.02% 1251
2015
Q2
$1.71M Sell
15,000
-1,400
-9% -$170K 0.01% 1594
2015
Q1
$1.71M Sell
16,400
-300
-2% -$32K 0.01% 1413
2014
Q4
$2.01M Buy
16,700
+7,200
+76% +$946K 0.02% 1325
2014
Q3
$1.39M Buy
9,500
+9,100
+2,275% +$1.4M 0.01% 1549
2014
Q2
$67K Buy
+400
New +$71.2K ﹤0.01% 3926
2013
Q3
Sell
-29,300
Closed -$4.44K 5136
2013
Q2
$4.44K Buy
+29,300
New +$4.15M 0.02% 846

Other funds holding CLB

PEAK6 Group's CLB Position: Q2 2018 in Review

PEAK6 Group increased its Core Laboratories (CLB) stake by 66% in Q2 2018, buying an estimated $74.5K and bringing the position to 1,544 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3356.

PEAK6 Group first reported a position in CLB in Q4 2013 and has held it in 13 quarters since. The position peaked at $2.46M in Q3 2014. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.

  • PEAK6 Group held 1,544 shares of Core Laboratories worth $195K as of Q2 2018.
  • PEAK6 Group bought 612 Core Laboratories shares in Q2 2018, an estimated $74.5K.
  • Core Laboratories made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3356 holding.
  • PEAK6 Group first reported a position in Core Laboratories in Q4 2013 and has held it in 13 quarters since.
  • PEAK6 Group's Core Laboratories position peaked at $2.46M in Q3 2014.
  • 374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.